Viability and drug sensitivity of M. leprae isolated from long-term WHO/MDT treated multibacillary leprosy patients.
ALERT, Addis Ababa, Ethiopia.
H
H
Habtemariam
D000818:Animals; D001707:Biopsy, Needle; D003140:Communicable Disease Control / Q000379:methods / Q000592:standards; D004359:Drug Therapy, Combination; D005002:Ethiopia; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage*; D007918:Leprosy / Q000188:drug therapy* / Q000382:microbiology* / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008826:Microbial Sensitivity Tests; D009166:Mycobacterium leprae / Q000187:drug effects* / Q000302:isolation & purification; D014944:World Health Organization
D007917:Leprostatic Agents